Breast Cancer Risk for Women With a TP53 Pathogenic Variant Reply

被引：0
|
作者：
Fortuno, Cristina [1 ]
Spurdle, Amanda B. [1 ]
James, Paul A. [2 ,3 ]
机构：
[1] QIMR Berghofer Med Res Inst, Populat Hlth Program, Brisbane, Qld, Australia
[2] Peter MacCallum Canc Ctr, Parkville Familial Canc Ctr, Melbourne, Vic, Australia
[3] Royal Melbourne Hosp, Melbourne, Vic, Australia
来源：
JCO PRECISION ONCOLOGY | 2024年 / 8卷
关键词：
D O I：
10.1200/PO.24.00270
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] TP53 gene polymorphisms and breast cancer in Croatian women: a pilot study
    Bisof, V.
    Salihovic, M. Pericic
    Narancic, N. Smolej
    Skaric-Juric, T.
    Jakic-Razumovic, J.
    Janicijevic, B.
    Turek, S.
    Rudan, P.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 31 (05) : 539 - 544
  • [22] TP53 mutations in head and neck cancer -: Reply
    Koch, Wayne
    Poeta, M. Luana
    Manola, Judith
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11): : 1195 - 1195
  • [23] TP53 Gene and Cancer Resistance in Elephants Reply
    Schiffman, Joshua D.
    Schmitt, Dennis L.
    Maley, Carlo C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (16): : 1790 - 1791
  • [24] Clinical Characteristics and Chemosensitivity in Germline TP53 Pathogenic Variant Cases Identified by Cancer Genomic Testing
    Saito, Yosuke
    Hoshi, Yuki
    Sato, Masamichi
    Seino, Manabu
    Watanabe, Norikazu
    Kawai, Masaaki
    Suzuki, Shuhei
    CANCER GENOMICS & PROTEOMICS, 2025, 22 (02) : 354 - 362
  • [25] BRCA1 Intragenic Duplication Combined with a Likely Pathogenic TP53 Variant in a Patient with Triple-Negative Breast Cancer: Clinical Risk and Management
    Ea, Vuthy
    Berthozat, Claudine
    Dreyfus, Helene
    Legrand, Clementine
    Rousselet, Estelle
    Peysselon, Magalie
    Baudet, Laura
    Martinez, Guillaume
    Coutton, Charles
    Bidart, Marie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [26] TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population
    Amir Hossain
    Gazi Md. Monjur Murshid
    Md. Nazmul Hasan Zilani
    Fahrima Islam
    Razia Sultana
    Tamanna Sultana
    Md. Golam Hossain
    Md. Mustafizur Rahman
    Breast Cancer, 2017, 24 : 571 - 578
  • [27] Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk
    Damin, Andrea P. S.
    Frazzon, Ana P. G.
    Damin, Daniel C.
    Roehe, Adriana
    Hermes, Vanessa
    Zettler, Claudio
    Alexandre, Claudio O. P.
    CANCER DETECTION AND PREVENTION, 2006, 30 (06): : 523 - 529
  • [28] TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population
    Hossain, Amir
    Murshid, Gazi Md. Monjur
    Zilani, Md. Nazmul Hasan
    Islam, Fahrima
    Sultana, Razia
    Sultana, Tamanna
    Hossain, Md. Golam
    Rahman, Md. Mustafizur
    BREAST CANCER, 2017, 24 (04) : 571 - 578
  • [29] Evolution of germline TP53 variant classification in children with cancer
    Tallis, E.
    Scollon, S.
    Ritter, D. I.
    Plon, S. E.
    CANCER GENETICS, 2022, 264 : 29 - 32
  • [30] TP53 c.542G>A identified as a Swedish founder variant with a risk of predominantly breast cancer
    Sun-Zhang, Alexander
    Omran, Meis
    Liu, Yaxuan
    Tham, Emma
    Lagercrantz, Svetlana Bajlica
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1739 - 1739
12345